Eva Guinan, MD

Director of Translational Research, Dept of Radiation Oncology

Associate Professor of Radiation Oncology, Harvard Medical School

    Contact: 617-632-4932
  • Fax: 617-632-3770

Medical Services

Specialties

  • Hematopoietic Stem Cell Transplantation
  • Bone Marrow Failure Disorders
  • Aplastic Anemia
  • Myelodysplasia
  • Regimen Related Toxicity

Departments

  • Hematology / Oncology

Programs

  • Stem Cell Transplantation
To schedule an appointment: Call 617-632-4932

Experience and Education

Education

Medical School

Harvard Medical School, 1980

Boston, MA

Internship

Boston Children's Hospital, 1980-1981

Boston, MA

Residency, Pediatrics

Boston Children's Hospital, 1981-1982

Boston, MA

Fellowship, Pediatric Hematology/Oncology

Children's Hospital Boston / Dana Farber Cancer Institute, 1982-1984

Boston, MA

Certifications

  • Pediatrics, Pediatric Hematology/Oncology

Professional History

Research

Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multi-organ failure post stem cell transplantation: a multi-center, randomized, dose-finding trial. Biol Blood Marrow Transplant (in press) Davies JK, Gribben JG, Brennan LL, Yuk D, Nadler LM, Guinan EC. Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of two phase I studies. Blood 2008; 112(6): 2232-41 Davies JK, Nadler LM, Guinan EC. Expansion of allospecific regulatory T cells after anergized mismatched bone marrow transplantation. Sci Transl Med 2009; 1(1): 1ra3. Bone Marrow Transplantation and Complications, Growth Factor Therapy, Bone Marrow Failure Syndromes Transplantation of anergic histoincompatible bone marrow (N Engl J Med 340:1704, 1999) Hematopoietic growth factors trials in pediatric bone marrow failure syndromes (Br J Haematol 103:304, 1998)· Neutrophil defense in BMT patients (Transplantation 73:1522, 2002; Pediatr Infect Dis J 22: 978, 2003) Metabolism and energy expenditure after BMT (Am J Clin Nutr 78:104, 2003) T cell memory after BMT (Blood 106: 1749, 2005

To schedule an appointment: Call 617-632-4932

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close